Aspen Aerogels Inc (ASPN, Financial) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $109.36 million, and the earnings are expected to come in at -$0.08 per share. The full year 2024's revenue is expected to be $415.75 million and the earnings are expected to be $0.16 per share. More detailed estimate data can be found on the Forecast page.
Aspen Aerogels Inc (ASPN, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Aspen Aerogels Inc (ASPN) for the full year 2024 have increased from $393.52 million to $415.75 million. For 2025, the estimates have declined from $551.64 million to $517.39 million. Earnings estimates for the full year 2024 have risen from $0.07 per share to $0.16 per share, while for 2025, they have decreased from $0.62 per share to $0.56 per share.
Aspen Aerogels Inc (ASPN, Financial) Reported History
In the previous quarter of 2024-06-30, Aspen Aerogels Inc's (ASPN) actual revenue was $117.77 million, which beat analysts' revenue expectations of $101.43 million by 16.11%. Aspen Aerogels Inc's (ASPN) actual earnings were $0.21 per share, which beat analysts' earnings expectations of $0.05 per share by 303.85%. After releasing the results, Aspen Aerogels Inc (ASPN) was up by 16% in one day.
Aspen Aerogels Inc (ASPN, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 11 analysts, the average target price for Aspen Aerogels Inc (ASPN) is $33.45 with a high estimate of $41 and a low estimate of $25. The average target implies an upside of 80.74% from the current price of $18.51.
Based on GuruFocus estimates, the estimated GF Value for Aspen Aerogels Inc (ASPN, Financial) in one year is $22.45, suggesting an upside of 21.29% from the current price of $18.51.
Based on the consensus recommendation from 11 brokerage firms, Aspen Aerogels Inc's (ASPN, Financial) average brokerage recommendation is currently 1.9, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies a Strong Buy, and 5 denotes a Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
